BRWA
ANIK icon

B. Riley Wealth Advisors’s Anika Therapeutics ANIK Stock Holding History

B. Riley Wealth Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-30
Closed -$1K – 640
2014
Q4 		$1K Buy
+30
New +$1.17K ﹤0.01% 3515
2014
Q3 		– Sell
-30
Closed -$1.39K – 716
2014
Q2 		$1.39K Buy
+30
New +$1.33K ﹤0.01% 2269

Other funds holding ANIK

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
LCP
Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

B. Riley Wealth Advisors's ANIK Position: Q1 2015 in Review

B. Riley Wealth Advisors sold out of Anika Therapeutics (ANIK) in Q1 2015, closing a stake of 30 shares — an estimated $1K sold.

B. Riley Wealth Advisors first reported a position in ANIK in Q2 2014 and held it in 2 quarters. The position peaked at $1.39K in Q2 2014. 159 funds tracked by Wall St. Rank hold ANIK as of Q1 2015.

  • B. Riley Wealth Advisors reported no remaining Anika Therapeutics position as of Q1 2015 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 30 Anika Therapeutics shares in Q1 2015, an estimated $1K.
  • B. Riley Wealth Advisors first reported a position in Anika Therapeutics in Q2 2014 and held it in 2 quarters.
  • B. Riley Wealth Advisors's Anika Therapeutics position peaked at $1.39K in Q2 2014.
  • 159 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2015.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2015, filed 14 May 2015.